ArticleInternal and emergency medicine2026
Increased risk of incident and recurrent urinary tract infection in autosomal dominant polycystic kidney disease: a contemporary propensity score-matched cohort study.
Article in Internal and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Urinary tract infection (UTI) is a clinically important complication of autosomal dominant polycystic kidney disease (ADPKD), often involving upper urinary tract and cyst infections. However, most epidemiologic data were generated decades ago, prior to contemporary advances in ADPKD management. We evaluated the current risk of incident and recurrent UTI in adults with ADPKD. Using the National Taiwan University Hospital Integrated Medical Database (2006-2021), adults with ADPKD were propensity score matched (1:4) to individuals without cystic kidney disease by age, sex, and chronic kidney disease (CKD) stage. Participants with prior UTI were excluded. Incident UTI was identified using validated International Classification of Disease codes. Cox proportional hazards models estimated adjusted hazard ratios (aHRs) controlling for demographics, comorbidities, medications, and estimated glomerular filtration rate. Recurrent UTI (≥ 2 episodes) risk was assessed in sensitivity analyses. The cohort included 1,044 patients with ADPKD and 4,176 matched controls (mean follow-up 4.2 years). Incident UTI occurred in 17.9% of ADPKD patients and 15.6% of controls (45.96 vs. 36.24 per 1,000 patient-years). This represented an absolute difference of 2.3 percentage points. ADPKD was independently associated with increased incident UTI risk (aHR 1.20, 95% confidence internal (CI) 1.02-1.42). The association was more pronounced in males (aHR 1.59) and in CKD stages 3b-5 (aHR 1.51). ADPKD was also associated with recurrent UTI (incidence rate ratio 1.32, 95% CI 1.15-1.51). In the contemporary era, ADPKD remains independently associated with increased risk of incident and recurrent UTI, although the absolute increase in UTI incidence was moderate. Targeted surveillance and preventive strategies may be warranted in high-risk subgroups.
Indexed as
Identifiers
42684643What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.